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Celiac disease is a T-cell mediated chronic inflammatory
disorder with an autoimmune component. Altered pro-
cessing by intraluminal enzymes, changes in intestinal
permeability, and activation of innate immunity
mechanisms seems to precede the activation of the
adaptive response. Significant progress has been made in
the understanding of the cellular and molecular basis of
CD and in the consequent identification of potential tar-
gets for therapy. Recently, it has been shown that gliadin
peptides are highly resistant to digestive processing by
pancreatic and brush border proteases. Enzyme supple-
ment therapy using bacterial prolyl endopeptidases has
been proposed to destroy T-cell multipotent epitopes.
The identification of T-cell stimulatory gliadin
sequences is important. Breeding programs and/or
transgenic technology may lead to production of wheat
that is devoid of biologically active peptide sequences.
The identification of specific epitopes may also provide
a target for immunomodulation of antigenic peptides.
Other promising areas include preventing gliadin pre-
sentation to T cells by blocking HLA binding sites, use
of tTG inhibitors, and assessing IL-10 as a tool for pro-
moting tolerance. However, evidence that gluten toxicity
is not dependent only on T-cell recognition is growing;
activation of innate immunity has been demonstrated
and antibodies to IL-15 proposed, particularly in refrac-
tory sprue because of the IEL activating role of IL-15.
However, one should realize that CD is a benign disease
and dietary treatment is safe, although strenuous An
immunomodulatory approach will need to have a safety
profile equivalent to that of the GFD, but with the
advantage of increased compliance. Another area of
important changes for CD concerns the diagnostic pro-
tocol. In 1990 ESPGHAN has revised its former diag-
nostic criteria laid down in 1970. The two requirements
mandatory for the diagnosis of celiac disease (CD)
remain: 1) the finding of villous atrophy with
hyperplasia of the crypts and abnormal surface epithe-
lium, while the patient is eating adequate amounts of
gluten; and 2) a full clinical remission after withdrawal
of gluten from the diet. However, important changes
that might have an impact on the diagnostic procedures
for CD, have occurred in recent years. Tests based on
the detection of anti-endomysium antibodies (EMA),
and subsequently of anti-tTG, have been increasingly
used as an initial screen for CD. Serological tests are lar-
gely responsible for the recognition that CD is not a
rare disease; moreover, with the notion of the relatively
high prevalence of CD has become increasingly recog-
nised its broad spectrum of clinical presentations. The
growing contribution of serology, together with the
recognition of a wider spectrum of histological changes
(see below), and the contribution by genetic tests,
demonstrate the necessity to move on to a revised diag-
nostic approach, but until serological methods are
improved, the genetic make up of celiac patients is bet-
ter defined, it seems wise for a diagnosis of celiac dis-
ease still rely on a combined approach based of clinical
criteria, histology, serology and genetics.
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